Bio-Reference Laboratories Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bio-Reference Laboratories Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7120
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio-Reference Laboratories Inc (Bio-Reference) a subsidiary of Opko Health, Inc., is a full service clinical laboratory that specializes in genetic testing. The company provides comprehensive range of tests that focus on molecular diagnostics, genetics, anatomical pathology, oncology, and women’s health. Besides clinical testing operations, Bio-Reference also provides business solutions such as data and analytics and clinical knowledge management services. The company offers testing and related services to both primary care and specialty health care segments which include physician offices, clinics, long term care facilities, hospitals, employers, governmental units and correctional institutions. Bio-Reference is headquartered in Elmwood Park, New Jersey, the US.

Bio-Reference Laboratories Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bio-Reference Laboratories Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Bio-Reference Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bio-Reference Laboratories Inc, Medical Equipment, Deal Details 10
Venture Financing 10
InCellDx Raises US$4 Million In Venture Financing 10
Bio-Reference Labs Enters Into Licensing Agreement With University of Washington 11
Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 12
Acquisition 13
Opko Health Acquires Bio-Reference Labs 13
BioReference Labs To Acquire Edge Bioserv From Edge BioSystems 15
Bio-Reference Laboratories Inc – Key Competitors 16
Bio-Reference Laboratories Inc – Key Employees 17
Bio-Reference Laboratories Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Legal and Regulatory 19
Dec 12, 2017: BioReference Laboratories Supports ACLA Suit Calling to Rescind PAMA Reimbursement Rate 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bio-Reference Laboratories Inc, Medical Equipment, Key Facts 2
Bio-Reference Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bio-Reference Laboratories Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bio-Reference Laboratories Inc, Deals By Market, 2012 to YTD 2018 8
Bio-Reference Laboratories Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InCellDx Raises US$4 Million In Venture Financing 10
Bio-Reference Labs Enters Into Licensing Agreement With University of Washington 11
Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 12
Opko Health Acquires Bio-Reference Labs 13
BioReference Labs To Acquire Edge Bioserv From Edge BioSystems 15
Bio-Reference Laboratories Inc, Key Competitors 16
Bio-Reference Laboratories Inc, Key Employees 17
Bio-Reference Laboratories Inc, Subsidiaries 18

List of Figures
Bio-Reference Laboratories Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bio-Reference Laboratories Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Bio-Reference Laboratories Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bio-Reference Laboratories Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Bio-Reference Laboratories Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BioCryst Pharmaceuticals Inc (BCRX)-製薬・医療分野:企業M&A・提携分析
    Summary BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrat …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bank of Singapore Ltd.:企業の戦略・SWOT・財務情報
    Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Indoco Remedies Ltd (INDOCO):企業の財務・戦略的SWOT分析
    Summary Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervo …
  • Bureau Veritas SA (BVI):石油・ガス:M&Aディール及び事業提携情報
    Summary Bureau Veritas SA (Bureau Veritas) is a provider of testing, inspection and certification services. The company offers asset management, certification, consulting, inspection and audits, testing and analysis, and training. It serves aeronautics, agriculture, automotive, construction and real …
  • T-Mobile US, Inc.:企業の戦略・SWOT・財務情報
    T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report Summary T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • gel-e Inc:製品パイプライン分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Didion Milling Inc.:企業の戦略・SWOT・財務情報
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aurora Health Care Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Health Care Inc (AHC) is an integrated, not-for-profit, health care system that provides inpatient and outpatient health care. The organization offers its healthcare services to communities throughout eastern Wisconsin and northern Illinois. Its service offerings include primary and s …
  • Avenue Supermarts Limited (DMART):企業の財務・戦略的SWOT分析
    Avenue Supermarts Limited (DMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析
    RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provi …
  • Pedernales Electric Cooperative, Inc.:発電所・企業SWOT分析
    Pedernales Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • 4SC AG (VSC):製薬・医療:M&Aディール及び事業提携情報
    Summary 4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at v …
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a biopharmaceutical company which focus on the discovery, development and commercialization of novel small molecule drugs to treat cancer. The company’s marketed product COPIKTRA, an oral inhibitor of phosphoinositide 3-kinase (PI3K) is used to hematologic malignan …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆